Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ATORVASTATIN vs ROSUVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ATORVASTATIN vs ROSUVASTATIN: Safety Overview

Metric ATORVASTATIN ROSUVASTATIN
Total FAERS Reports 79,519 36,332
Deaths Reported 4,992 1,536
Death Rate 6.3% 4.2%
Hospitalizations 24,078 11,195
Average Patient Age 64.4 yrs 66.1 yrs
% Female Patients 58.5% 54.9%
FDA Approval Date Apr 5, 2013 Apr 1, 2020
Manufacturer REMEDYREPACK INC. Umedica Laboratories USA Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription